AI Engines For more Details: Perplexity Kagi Labs You
Asthma: Budesonide is commonly prescribed as an inhaled corticosteroid (ICS) for the long-term management of asthma. It helps reduce inflammation in the airways, thereby improving breathing and preventing asthma symptoms such as wheezing, coughing, and shortness of breath.
Chronic Obstructive Pulmonary Disease (COPD): Budesonide may be used in combination with a long-acting beta agonist (LABA) to manage symptoms of COPD, including chronic bronchitis and emphysema. The combination therapy helps reduce airway inflammation and improve lung function.
Allergic Rhinitis: Budesonide nasal spray is effective in relieving symptoms of allergic rhinitis (hay fever), such as nasal congestion, sneezing, itching, and runny nose. It reduces inflammation in the nasal passages and provides symptomatic relief.
Nasal Polyps: Budesonide nasal spray is also used to treat nasal polyps, which are noncancerous growths in the nasal passages. It helps reduce the size of nasal polyps and alleviate symptoms such as nasal congestion and difficulty breathing through the nose.
Inflammatory Bowel Disease (IBD): Budesonide is used in the treatment of mild to moderate Crohn's disease and ulcerative colitis, two types of IBD. It helps reduce inflammation in the gastrointestinal tract, leading to symptom relief and disease remission.
Topical Formulations: Budesonide is available in various formulations, including inhalers, nasal sprays, oral capsules, and rectal foams or enemas, depending on the specific condition being treated and the targeted site of action.
Anti-inflammatory Action: Budesonide exerts its therapeutic effects by inhibiting the production of inflammatory mediators and suppressing the immune response. This helps alleviate inflammation, swelling, and irritation associated with inflammatory conditions.
Local and Systemic Side Effects: While budesonide is generally well-tolerated, long-term use or high doses may increase the risk of side effects. Common side effects include sore throat, hoarseness, coughing, dry mouth, oral thrush (candidiasis), and nosebleeds (with nasal spray). Systemic side effects such as adrenal suppression, osteoporosis, and increased susceptibility to infections are more likely with oral formulations.
Monitoring and Adverse Reactions: Patients taking budesonide should be monitored regularly for potential adverse effects, particularly with long-term use. It is important to use the lowest effective dose for the shortest duration necessary to achieve symptom control and to follow healthcare provider recommendations closely.
Contraindications: Budesonide is contraindicated in patients with a known hypersensitivity to corticosteroids or any of the components of the formulation. It should be used with caution in patients with certain medical conditions, such as diabetes, hypertension, glaucoma, and osteoporosis.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | 0.2 | |
Acne | 0.4 | -0.4 | |
ADHD | 2.9 | 0.8 | 2.62 |
Age-Related Macular Degeneration and Glaucoma | 0.6 | 0.1 | 5 |
Allergic Rhinitis (Hay Fever) | 2.2 | 2.5 | -0.14 |
Allergies | 5.9 | 2.8 | 1.11 |
Allergy to milk products | 1.7 | 0.8 | 1.13 |
Alopecia (Hair Loss) | 1.4 | 1.4 | |
Alzheimer's disease | 4.3 | 3.6 | 0.19 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.2 | 0.9 | 1.44 |
Ankylosing spondylitis | 3 | 0.8 | 2.75 |
Anorexia Nervosa | 1.5 | 1.5 | 0 |
Antiphospholipid syndrome (APS) | 0.3 | 0.2 | 0.5 |
Asthma | 3.5 | 2.4 | 0.46 |
Atherosclerosis | 1.4 | 1.1 | 0.27 |
Atrial fibrillation | 2.6 | 1 | 1.6 |
Autism | 6.9 | 5.8 | 0.19 |
Autoimmune Disease | 0.5 | 0.5 | 0 |
Barrett esophagus cancer | 0.4 | 0.1 | 3 |
benign prostatic hyperplasia | 0 | 0.1 | 0 |
Biofilm | 1.6 | 1.6 | |
Bipolar Disorder | 1 | 1.2 | -0.2 |
Brain Trauma | 1.1 | 0.8 | 0.38 |
Breast Cancer | 0.1 | 0.1 | |
Cancer (General) | 0.7 | 1.5 | -1.14 |
Carcinoma | 3.1 | 2.5 | 0.24 |
Celiac Disease | 1.9 | 3.5 | -0.84 |
Cerebral Palsy | 1.3 | 0.9 | 0.44 |
Chronic Fatigue Syndrome | 4.1 | 6 | -0.46 |
Chronic Kidney Disease | 3 | 1.6 | 0.88 |
Chronic Lyme | 0.6 | 0.2 | 2 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.2 | 0.9 | 0.33 |
Chronic Urticaria (Hives) | 0.7 | 0.7 | 0 |
Coagulation / Micro clot triggering bacteria | 0.4 | 1 | -1.5 |
Cognitive Function | 1.9 | 1 | 0.9 |
Colorectal Cancer | 3.2 | 1.3 | 1.46 |
Constipation | 0.5 | 0.6 | -0.2 |
Coronary artery disease | 1.6 | 2 | -0.25 |
COVID-19 | 7.8 | 9.1 | -0.17 |
Crohn's Disease | 5 | 3.8 | 0.32 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.1 | 1.6 | -15 |
d-lactic acidosis (one form of brain fog) | 0.1 | 0.1 | |
deep vein thrombosis | 0.7 | 0.6 | 0.17 |
Denture Wearers Oral Shifts | 0.9 | 0.9 | |
Depression | 6.7 | 7 | -0.04 |
Dermatomyositis | 0.1 | 0.4 | -3 |
Eczema | 1.1 | 1.3 | -0.18 |
Endometriosis | 2 | 1.4 | 0.43 |
Eosinophilic Esophagitis | 0.6 | -0.6 | |
Epilepsy | 2.2 | 2.2 | 0 |
erectile dysfunction | 0.2 | 0.4 | -1 |
Fibromyalgia | 2.3 | 1.3 | 0.77 |
Functional constipation / chronic idiopathic constipation | 3 | 2.1 | 0.43 |
gallstone disease (gsd) | 2.4 | 0.7 | 2.43 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 1.2 | -1 |
Generalized anxiety disorder | 2 | 1.8 | 0.11 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.1 | -0.1 | |
Gout | 1 | 0.6 | 0.67 |
Graves' disease | 1.7 | 2.8 | -0.65 |
Gulf War Syndrome | 1 | 1.1 | -0.1 |
Halitosis | 0.7 | 0.1 | 6 |
Hashimoto's thyroiditis | 2.7 | 1 | 1.7 |
Heart Failure | 2.1 | 1.6 | 0.31 |
hemorrhagic stroke | 0.5 | 0.5 | |
Hidradenitis Suppurativa | 0.5 | 0.4 | 0.25 |
High Histamine/low DAO | 0.4 | 0.6 | -0.5 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.5 | 0 |
hyperglycemia | 0.9 | 1.8 | -1 |
Hyperlipidemia (High Blood Fats) | 1.3 | 0.5 | 1.6 |
hypersomnia | 1.2 | -1.2 | |
hypertension (High Blood Pressure | 3.6 | 4 | -0.11 |
Hypothyroidism | 0.2 | 1.3 | -5.5 |
Hypoxia | 1.5 | 1.5 | |
IgA nephropathy (IgAN) | 0.9 | 2.6 | -1.89 |
Inflammatory Bowel Disease | 5.2 | 7.5 | -0.44 |
Insomnia | 2 | 2.2 | -0.1 |
Intelligence | 0.8 | 0.1 | 7 |
Intracranial aneurysms | 1 | 0.7 | 0.43 |
Irritable Bowel Syndrome | 4.5 | 3.6 | 0.25 |
ischemic stroke | 2.5 | 0.2 | 11.5 |
Liver Cirrhosis | 4.7 | 3.2 | 0.47 |
Long COVID | 4.7 | 6.5 | -0.38 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 0.3 | 1.8 | -5 |
Lymphoma | 0 | 0 | |
Mast Cell Issues / mastitis | 0.2 | 0.9 | -3.5 |
ME/CFS with IBS | 0.5 | 2.7 | -4.4 |
ME/CFS without IBS | 1.4 | 1.7 | -0.21 |
membranous nephropathy | 0.1 | 0.1 | |
Menopause | 2.1 | 0.3 | 6 |
Metabolic Syndrome | 5.6 | 6.1 | -0.09 |
Mood Disorders | 7.4 | 6.1 | 0.21 |
multiple chemical sensitivity [MCS] | 0.8 | 0.5 | 0.6 |
Multiple Sclerosis | 5.2 | 3 | 0.73 |
Multiple system atrophy (MSA) | 1.2 | 1.1 | 0.09 |
myasthenia gravis | 0.2 | 0.2 | 0 |
neuropathic pain | 0.2 | 1.5 | -6.5 |
Neuropathy (all types) | 1.1 | 0.8 | 0.38 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.1 | 4.6 | -0.48 |
NonCeliac Gluten Sensitivity | 2.1 | 0.5 | 3.2 |
Obesity | 7.6 | 5.8 | 0.31 |
obsessive-compulsive disorder | 3.5 | 3.2 | 0.09 |
Osteoarthritis | 1.7 | 1.2 | 0.42 |
Osteoporosis | 1.2 | 1.8 | -0.5 |
pancreatic cancer | 0.5 | 0.1 | 4 |
Parkinson's Disease | 6.4 | 3.5 | 0.83 |
Polycystic ovary syndrome | 4.2 | 2.8 | 0.5 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.6 | -5 |
Premenstrual dysphoric disorder | 1.3 | 0.1 | 12 |
primary biliary cholangitis | 1 | 0.7 | 0.43 |
Primary sclerosing cholangitis | 2 | 2.6 | -0.3 |
Psoriasis | 3.3 | 1.2 | 1.75 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 6.4 | 3 | 1.13 |
Rosacea | 0.7 | 0.2 | 2.5 |
Schizophrenia | 6.1 | 2.4 | 1.54 |
scoliosis | 0.5 | 0.5 | 0 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.4 | 2.1 | 0.14 |
Sleep Apnea | 1.8 | 1.1 | 0.64 |
Slow gastric motility / Gastroparesis | 0.8 | 0.4 | 1 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.1 | 0.6 | 0.83 |
Stress / posttraumatic stress disorder | 1.4 | 2.3 | -0.64 |
Systemic Lupus Erythematosus | 2.9 | 1.5 | 0.93 |
Tic Disorder | 0.9 | 1.6 | -0.78 |
Tourette syndrome | 0.8 | 0.1 | 7 |
Type 1 Diabetes | 3.1 | 2.7 | 0.15 |
Type 2 Diabetes | 5.7 | 4.6 | 0.24 |
Ulcerative colitis | 2.7 | 4.5 | -0.67 |
Unhealthy Ageing | 3.3 | 1.4 | 1.36 |
Vitiligo | 1.1 | 1.5 | -0.36 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]